Erik De Clercq And NotRépublique populaire de Chine
List of bibliographic references
Number of relevant bibliographic references: 13.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000110 | Guangdi Li ; Erik De Clercq | Therapeutic options for the 2019 novel coronavirus (2019-nCoV). |
| 001599 | Erik De Clercq | Potential antivirals and antiviral strategies against SARS coronavirus infections |
| 001A99 | Erik De Clercq [Belgique] | Highlights in Antiviral Drug Research: Antivirals at the Horizon |
| 002197 | Erik De Clercq [Belgique] | The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures |
| 002E67 | Erik De Clercq [Belgique] | Another ten stories in antiviral drug discovery (part C): “Old” and “new” antivirals, strategies, and perspectives |
| 003422 | Irene M. Lagoja [Belgique] ; Erik De Clercq [Belgique] | Anti‐influenza virus agents: Synthesis and mode of action |
| 004085 | Christophe Biot [Belgique, France] ; Wassim Daher [Belgique] ; Natascha Chavain [Belgique] ; Thierry Fandeur [Belgique] ; Jamal Khalife [Belgique] ; Daniel Dive [Belgique] ; Erik De Clercq [Belgique] | Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral Activities |
| 004196 | Jan Balzarini [Belgique] ; Els Keyaerts [Belgique] ; Leen Vijgen [Belgique] ; Frank Vandermeer [Pays-Bas] ; Miguel Stevens [Belgique] ; Erik De Clercq [Belgique] ; Herman Egberink [Pays-Bas] ; Marc Van Ranst [Belgique] | Pyridine N-oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell culture |
| 004357 | Erik De Clercq [Belgique] | Antiviral agents active against influenza A viruses |
| 004437 | Jan Balzarini [Belgique] ; Els Keyaerts [Belgique] ; Leen Vijgen [Belgique] ; Herman Egberink [Pays-Bas] ; Erik De Clercq [Belgique] ; Marc Van Ranst [Belgique] ; Svetlana S. Printsevskaya [Russie] ; Eugenia N. Olsufyeva [Russie] ; Svetlana E. Solovieva [Russie] ; Maria N. Preobrazhenskaya [Russie] | Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics |
| 005456 | Erik De Clercq | Antivirals and antiviral strategies |
| 006396 | Christopher Mcguigan [Royaume-Uni] ; Alison Jukes [Royaume-Uni] ; Sally Blewett [Royaume-Uni] ; Hubert Barucki [Royaume-Uni] ; Jonathan T. Erichsen [Royaume-Uni] ; Graciella Andrei [Belgique] ; Robert Snoeck [Belgique] ; Erik De Clercq [Belgique] ; Jan Balzarini [Belgique] | Halophenyl furanopyrimidines as potent and selective anti-VZV agents |
| 006468 | Chad E. Stephens [États-Unis] ; Takita M. Felder [États-Unis] ; J. Walter Sr Sowell [États-Unis] ; Graciela Andrei [Belgique] ; Jan Balzarini [Belgique] ; Robert Snoeck [Belgique] ; Erik De Clercq [Belgique] | Synthesis and antiviral/antitumor evaluation of 2-amino- and 2-carboxamido-3-arylsulfonylthiophenes and related compounds as a new class of diarylsulfones |
| This area was generated with Dilib version V0.6.33. |  |